Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$18.47 - $24.03 $359,500 - $467,719
-19,464 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$21.01 - $28.94 $77,148 - $106,267
3,672 Added 23.25%
19,464 $488,000
Q2 2019

Aug 14, 2019

BUY
$23.33 - $28.3 $368,427 - $446,913
15,792 New
15,792 $447,000
Q2 2018

Aug 14, 2018

SELL
$13.65 - $18.7 $220,338 - $301,855
-16,142 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$14.85 - $24.3 $239,708 - $392,250
16,142 New
16,142 $257,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.28B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.